Max Healthcare Institute Share Price
Sector: Healthcare Facilities
1261.45 -4.90 (-0.39%)
- 1D
- 5D
- 1M
- 3M
- 6M
- 1Y
- 5Y
- MAX
Price Range
Today’s Low
1255.60
Today’s High
1273.70
52 Week Low
837
52 Week High
1274.40
1259.00 -7.50 (-0.59%)
- 1D
- 5D
- 1M
- 3M
- 6M
- 1Y
- 5Y
- MAX
Price Range
Today’s Low
1255.10
Today’s High
1276
52 Week Low
836.60
52 Week High
1275
Key Metrics
- Market Cap (In Cr) 122631.46
- Beta 0.77
- Div. Yield (%) 0.12
- P/B 13.12
- TTM P/E 99.09
- Peg Ratio 5.52
- Sector P/E 22.44
- D/E 0
- Open Price 1266.55
- Prev Close 1266.35
Max Healthcare Institute Analysis
Price Analysis
-
1 Week8.9%
-
3 Months12.14%
-
6 Month9.59%
-
YTD12.26%
-
1 Year44.01%
Risk Meter
- 40% Low risk
- 40% Moderate risk
- 40% Balanced Risk
- 40% High risk
- 40% Extreme risk
Recos
- Strong Sell
- Sell
- Hold
- Buy
- Strong Buy
Analysts' Views
- Ratings
- Current
- 1 W Ago
- 1 M Ago
- 3 M Ago
- Strong Buy
- 6
- 6
- 6
- 6
- Buy
- 7
- 7
- 7
- 7
- Hold
- 3
- 3
- 3
- 3
- Sell
- 4
- 4
- 4
- 4
- Strong Sell
- 0.00
- 0.00
- 0.00
- 0.00
- Total
- 20
- 20
- 20
- 20
Max Healthcare Institute News
Mazagon Dock, Indian Hotels shares among likely largecap entrants
3 min read . 29 May 2025Stocks to watch: BEL, Vodafone Idea, Arvind Fashions among shares in focus today
1 min read . 19 May 2025Breakout stocks to buy or sell: Sumeet Bagadia recommends five shares to buy
1 min read . 07 Apr 2025Max Healthcare Institute Financials
- INCOME
- BALANCE SHEET
- Cashflow
- Period
- 2025
- Total Revenue
- 7028.46
- Selling/ General/ Admin Expenses Total
- 2648.71
- Depreciation/ Amortization
- 359.42
- Other Operating Expenses Total
- 1053.9
- Total Operating Expense
- 5612.71
- Operating Income
- 1415.75
- Net Income Before Taxes
- 1406.37
- Net Income
- 1075.88
- Diluted Normalized EPS
- 11.59
- Period
- 2025
- Total Assets
- 15214.48
- Total Liabilities
- 5833.61
- Total Equity
- 9380.87
- Tangible Book Valueper Share Common Eq
- 34.41
- Period
- 2025
- Cashfrom Operating Activities
- 1476.82
- Cashfrom Investing Activities
- -1631.74
- Cashfrom Financing Activities
- -163.8
- Net Changein Cash
- -318.6
- Period
- 2024
- Total Revenue
- 5406.02
- Selling/ General/ Admin Expenses Total
- 2698.1
- Depreciation/ Amortization
- 244.92
- Other Operating Expenses Total
- 8.22
- Total Operating Expense
- 4146.86
- Operating Income
- 1259.16
- Net Income Before Taxes
- 1365.32
- Net Income
- 1057.64
- Diluted Normalized EPS
- 10.83
- Period
- 2024
- Total Assets
- 11999.94
- Total Liabilities
- 3591.8
- Total Equity
- 8408.14
- Tangible Book Valueper Share Common Eq
- 29.07
- Period
- 2024
- Cashfrom Operating Activities
- 1156.52
- Cashfrom Investing Activities
- -1285.45
- Cashfrom Financing Activities
- -263.74
- Net Changein Cash
- -394.49
- Period
- 2023
- Total Revenue
- 4562.6
- Selling/ General/ Admin Expenses Total
- 2322.24
- Depreciation/ Amortization
- 232.19
- Other Operating Expenses Total
- 5.69
- Total Operating Expense
- 3551.05
- Operating Income
- 1011.55
- Net Income Before Taxes
- 1063.72
- Net Income
- 1103.51
- Diluted Normalized EPS
- 11.35
- Period
- 2023
- Total Assets
- 10101.85
- Total Liabilities
- 2692.26
- Total Equity
- 7409.59
- Tangible Book Valueper Share Common Eq
- 24.14
- Period
- 2023
- Cashfrom Operating Activities
- 1209.18
- Cashfrom Investing Activities
- -1187.01
- Cashfrom Financing Activities
- -288.56
- Net Changein Cash
- -266.39
- Period
- 2022
- Total Revenue
- 3931.46
- Selling/ General/ Admin Expenses Total
- 1981.15
- Depreciation/ Amortization
- 221.12
- Other Operating Expenses Total
- 3.81
- Total Operating Expense
- 3200.68
- Operating Income
- 730.78
- Net Income Before Taxes
- 738.9
- Net Income
- 605.05
- Diluted Normalized EPS
- 6.34
- Period
- 2022
- Total Assets
- 9189.13
- Total Liabilities
- 2906.66
- Total Equity
- 6282.47
- Tangible Book Valueper Share Common Eq
- 12.09
- Period
- 2022
- Cashfrom Operating Activities
- 748.49
- Cashfrom Investing Activities
- -771.77
- Cashfrom Financing Activities
- -294.17
- Net Changein Cash
- -317.45
- Period
- 2021
- Total Revenue
- 2504.67
- Selling/ General/ Admin Expenses Total
- 1447.92
- Depreciation/ Amortization
- 174.09
- Other Operating Expenses Total
- 6.87
- Total Operating Expense
- 2508.36
- Operating Income
- -3.69
- Net Income Before Taxes
- -68.65
- Net Income
- -137.55
- Diluted Normalized EPS
- 0.17
- Period
- 2021
- Total Assets
- 8544.44
- Total Liabilities
- 2905.76
- Total Equity
- 5638.68
- Tangible Book Valueper Share Common Eq
- 8.8
- Period
- 2021
- Cashfrom Operating Activities
- 397.25
- Cashfrom Investing Activities
- -73
- Cashfrom Financing Activities
- 191.33
- Net Changein Cash
- 515.58
- Period
- 2020
- Total Revenue
- 1884.46
- Selling/ General/ Admin Expenses Total
- 1172.06
- Depreciation/ Amortization
- 119.74
- Other Operating Expenses Total
- -7.93
- Total Operating Expense
- 1714.58
- Operating Income
- 169.88
- Net Income Before Taxes
- 89.08
- Net Income
- 95.34
- Diluted Normalized EPS
- 1.05
- Period
- 2020
- Total Assets
- 3824.38
- Total Liabilities
- 2836.97
- Total Equity
- 987.41
- Tangible Book Valueper Share Common Eq
- -2.74
- Period
- 2020
- Cashfrom Operating Activities
- 249.82
- Cashfrom Investing Activities
- -126.68
- Cashfrom Financing Activities
- 144.05
- Net Changein Cash
- 267.19
- Period
- 2019
- Total Revenue
- 1691.02
- Selling/ General/ Admin Expenses Total
- 1119.93
- Depreciation/ Amortization
- 102.64
- Other Operating Expenses Total
- 2.87
- Total Operating Expense
- 1636.96
- Operating Income
- 54.06
- Net Income Before Taxes
- 8.32
- Net Income
- -3.01
- Diluted Normalized EPS
- -0.03
- Period
- 2019
- Total Assets
- 3365.62
- Total Liabilities
- 2402.43
- Total Equity
- 963.19
- Tangible Book Valueper Share Common Eq
- -3.21
- Period
- 2019
- Cashfrom Operating Activities
- 88.95
- Cashfrom Investing Activities
- -16.53
- Cashfrom Financing Activities
- -73.95
- Net Changein Cash
- -1.53
- Period
- 2025-03-31
- Total Revenue
- 1909.74
- Selling/ General/ Admin Expenses Total
- 721.93
- Depreciation/ Amortization
- 100.83
- Other Operating Expenses Total
- 266.76
- Total Operating Expense
- 1498.95
- Operating Income
- 410.79
- Net Income Before Taxes
- 402.5
- Net Income
- 319
- Diluted Normalized EPS
- 3.28
- Period
- 2025-03-31
- Total Assets
- 15214.48
- Total Liabilities
- 5833.61
- Total Equity
- 9380.87
- Tangible Book Valueper Share Common Eq
- 34.41
- Period
- 2025-03-31
- Cashfrom Operating Activities
- 1476.82
- Cashfrom Investing Activities
- -1631.74
- Cashfrom Financing Activities
- -163.8
- Net Changein Cash
- -318.6
- Period
- 2024-12-31
- Total Revenue
- 1868.31
- Selling/ General/ Admin Expenses Total
- 690.74
- Depreciation/ Amortization
- 97.54
- Other Operating Expenses Total
- 286.62
- Total Operating Expense
- 1540.35
- Operating Income
- 327.96
- Net Income Before Taxes
- 308.87
- Net Income
- 238.8
- Diluted Normalized EPS
- 3.02
- Period
- 2024-12-31
- Period
- 2024-12-31
- Period
- 2024-09-30
- Total Revenue
- 1707.46
- Selling/ General/ Admin Expenses Total
- 638.32
- Depreciation/ Amortization
- 84.15
- Other Operating Expenses Total
- 269.36
- Total Operating Expense
- 1341.07
- Operating Income
- 366.39
- Net Income Before Taxes
- 373.69
- Net Income
- 281.81
- Diluted Normalized EPS
- 2.88
- Period
- 2024-09-30
- Total Assets
- 13126.87
- Total Liabilities
- 4327.81
- Total Equity
- 8799.06
- Tangible Book Valueper Share Common Eq
- 33.68
- Period
- 2024-09-30
- Cashfrom Operating Activities
- 576.02
- Cashfrom Investing Activities
- -569.94
- Cashfrom Financing Activities
- -21.73
- Net Changein Cash
- -15.88
- Period
- 2024-06-30
- Total Revenue
- 1542.95
- Selling/ General/ Admin Expenses Total
- 597.72
- Depreciation/ Amortization
- 76.9
- Other Operating Expenses Total
- 231.26
- Total Operating Expense
- 1232.44
- Operating Income
- 310.51
- Net Income Before Taxes
- 321.31
- Net Income
- 236.27
- Diluted Normalized EPS
- 2.42
- Period
- 2024-06-30
- Period
- 2024-06-30
- Period
- 2024-03-31
- Total Revenue
- 1422.9
- Selling/ General/ Admin Expenses Total
- 534.39
- Depreciation/ Amortization
- 70.32
- Other Operating Expenses Total
- 211.38
- Total Operating Expense
- 1111.69
- Operating Income
- 311.21
- Net Income Before Taxes
- 335.73
- Net Income
- 251.54
- Diluted Normalized EPS
- 2.57
- Period
- 2024-03-31
- Total Assets
- 11999.94
- Total Liabilities
- 3591.8
- Total Equity
- 8408.14
- Tangible Book Valueper Share Common Eq
- 29.07
- Period
- 2024-03-31
- Cashfrom Operating Activities
- 1156.52
- Cashfrom Investing Activities
- -1285.45
- Cashfrom Financing Activities
- -263.74
- Net Changein Cash
- -394.49
- Period
- 2023-12-31
- Total Revenue
- 1334.97
- Selling/ General/ Admin Expenses Total
- 506.73
- Depreciation/ Amortization
- 60.96
- Other Operating Expenses Total
- 175.1
- Total Operating Expense
- 1010.07
- Operating Income
- 324.9
- Net Income Before Taxes
- 359.68
- Net Income
- 289.34
- Diluted Normalized EPS
- 2.97
- Period
- 2023-12-31
- Period
- 2023-12-31
Forecast
Income Sheet (In Cr)
Net Income Vs Revenue
Returns Metrics (In Cr)
ROA Vs ROE
Forecast
Balance Sheet
Asset vs Liability
Forecast
Cash Flow
Operating vs Investing
Max Healthcare Institute Technical
Moving Average
SMA
- 5 Day1189.43
- 10 Day1203.95
- 20 Day1178.27
- 50 Day1149.64
- 100 Day1103.26
- 300 Day1065.25
Max Healthcare Institute Peers
- Price
- Ratio
- Name
- Latest Price
- Change
- % Change
- 52W High
- 52W Low
- Mkt. Cap
- Max Healthcare Institute
- 1261.45
- -4.9
- -0.39
- 1274.4
- 837
- 122631.46
- Apollo Hospitals Enterprise
- 7151.05
- 49.4
- 0.7
- 7545.1
- 6002.15
- 102720.45
- Fortis Healthcare
- 797.75
- 6.85
- 0.87
- 793.35
- 452.75
- 60354.51
- Narayana Hrudayalaya
- 2035
- -35.8
- -1.73
- 2145
- 1171.35
- 41624.71
- Global Health
- 1149.1
- 17.2
- 1.52
- 1323.85
- 936.05
- 30833.32
- Name
- P/E (X)
- P/B (X)
- ROE %
- OPM
- Max Healthcare Institute
- 106.94
- 12.84
- 11.25
- 15.91
- Apollo Hospitals Enterprise
- 70.03
- 12.33
- 15
- 5.46
- Fortis Healthcare
- 69.55
- 6.6
- 6.88
- 9.18
- Narayana Hrudayalaya
- 52.51
- 11.53
- 25.11
- 11.8
- Global Health
- 58.41
- 8.94
- 14.18
- 11.38
Max Healthcare Institute Shareholding
Shareholding Pattern
Shareholding Trend
Shareholding(%) v/s Date
Corporate Actions
- Board Meeting
- AGM
- Dividends
- Bonus
- Split
- Rights
- Meeting Date
- Purpose
- 20-May-25
- Audited Results & Final Dividend
- 30-Jan-25
- Quarterly Results
- 05-Nov-24
- Quarterly Results
- 01-Aug-24
- Quarterly Results
- 22-May-24
- Audited Results & Final Dividend
- 31-Jan-24
- Quarterly Results
- 06-Nov-23
- Quarterly Results
- 07-Aug-23
- Quarterly Results
- 16-May-23
- Audited Results & Final Dividend
- 02-Feb-23
- Quarterly Results & Others
- Meeting Date
- Announced on
- Purpose
- 20-Sept-24
- 12-Aug-24
- AGM
- 27-Sept-23
- 23-Aug-23
- AGM
- 17-Aug-23
- 17-Jul-23
- POM
- 26-Sept-22
- 31-Aug-22
- AGM
- 07-May-22
- 04-Apr-22
- POM
- 30-Sept-21
- 10-Aug-21
- AGM
- Announced on
- Record Date
- Ex-Dividend
- Dividend Value
- 20-May-25
- -
- -
- 1.5
- 22-May-24
- 23-Aug-24
- 23-Aug-24
- 1.5
- 16-May-23
- 08-Sept-23
- 08-Sept-23
- 1


